Skip to main content

Breadcrumb

  1. Home

Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay

PD-1 and LAG-3 synergize to drive tumor-infiltration of T cytotoxic cells in NSCLC tumors

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about PD-1 and LAG-3 synergize to drive tumor-infiltration of T cytotoxic cells in NSCLC tumors

Comparison of PD-L1 expression in primary and metastatic lung cancer biopsies

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Comparison of PD-L1 expression in primary and metastatic lung cancer biopsies

Analysis of Real-World PD-L1 Testing and PD-L1 IHC 28-8 and 22C3 Assay Concordance in Patients with Breast Cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Analysis of Real-World PD-L1 Testing and PD-L1 IHC 28-8 and 22C3 Assay Concordance in Patients with Breast Cancer

Spatial analytics of the tumor microenvironment on double stained immunohistochemistry images using deep learning

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Spatial analytics of the tumor microenvironment on double stained immunohistochemistry images using deep learning

Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay

Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors

Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC

Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Next page Next
  • Last page Last
Subscribe to